Tag: DLL3

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to DLL3

Innovent Biologics Inc (IVBIY) Partners with Roche for Novel DLL3 Antibody Drug Conjugate

Added to Collection on: 2025-01-02 00:03:24

Tags for this article:

Biotechnology
Roche
Antibody-drug conjugate
DLL3
Biopharmaceutical
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 ...

Added to Collection on: 2025-01-02 11:53:19

Tags for this article:

Biotechnology
Eli Lilly and Company
Research and development in the United States
Antibody-drug conjugate
Biopharmaceutical
DLL3
Cancer
Roche
Pharmaceutical industry in India
Lung cancer
Pharmaceutical industry in China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Roche Acquires Innovent's Lung Cancer Drug IBI3009 in $1 Billion Milestone Deal | IVBIY ...

Added to Collection on: 2025-01-01 23:34:06

Tags for this article:

Biotechnology
Antineoplastic drugs
Eli Lilly and Company
Research and development in the United States
Antibody-drug conjugate
Biopharmaceutical
DLL3
Roche
Cancer
Pharmaceutical industry in India
Chemotherapy
Lung cancer
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Roche and Innovent to Collaborate on Novel SCLC-Targeted ADC in Deal Worth Potentially ...

Added to Collection on: 2025-01-02 21:44:09

Tags for this article:

Biotechnology
Lung cancer
Eli Lilly and Company
Research and development in the United States
Antibody-drug conjugate
DLL3
Hepatocyte growth factor receptor
Roche
Small-cell carcinoma
innovent biologics
Innovent

Click the tags to see associated articles and topics

View Article Details
Reducing the Risks: Managing CRS, ICANS, and Skin Reactions in Emerging Lung Cancer ...

Added to Collection on: 2025-06-02 03:48:35

Tags for this article:

Immunology
Lung cancer
Immune system disorders
Rare diseases
Monoclonal antibodies
Cytokine release syndrome
Small-cell carcinoma
Bi-specific T-cell engager
DLL3
Tarlatamab
T cell
Commercial Resupply Services

Click the tags to see associated articles and topics

View Article Details
Book a Demo